The Efficacy of Tiotropium as a Steroid-Sparing Agent in Severe Asthma
People with severe asthma account for 5% to 10% of all asthmatic patients; however, this small group uses the majority of health care resources. Novel methods are needed to cope with the burden that this minority of patients places on the health care system. A severe asthma clinic patient, who was m...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2009/206506 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849405132315295744 |
|---|---|
| author | Anmol S Kapoor Sharla-Rae Olsen Cindy O’Hara Lakshmi Puttagunta Dilini Vethanayagam |
| author_facet | Anmol S Kapoor Sharla-Rae Olsen Cindy O’Hara Lakshmi Puttagunta Dilini Vethanayagam |
| author_sort | Anmol S Kapoor |
| collection | DOAJ |
| description | People with severe asthma account for 5% to 10% of all asthmatic patients; however, this small group uses the majority of health care resources. Novel methods are needed to cope with the burden that this minority of patients places on the health care system. A severe asthma clinic patient, who was monitored through the University of Alberta’s Virtual Asthma Clinic (Edmonton, Alberta) is presented. Despite optimization of his disease and individualized asthma education (provided by a certified asthma educator), the patient remained on oral glucocorticosteroids (OGS) to control his disease. Following optimization and stabilization, a further reduction in the dose of his OGS by the addition of the long-acting anticholinergic agent tiotropium bromide, was demonstrated. The role of tiotropium as a potential ‘steroid-sparing agent’ in severe refractory asthma is discussed, noting that if patients who are on OGS are not monitored for active inflammation, they may overuse the amount of prescribed systemic steroids, which can result in long-term steroid-related sequelae. |
| format | Article |
| id | doaj-art-4715ffc6f7d1486fae4b2bfcaea37299 |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2009-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-4715ffc6f7d1486fae4b2bfcaea372992025-08-20T03:36:45ZengWileyCanadian Respiratory Journal1198-22412009-01-011639910110.1155/2009/206506The Efficacy of Tiotropium as a Steroid-Sparing Agent in Severe AsthmaAnmol S Kapoor0Sharla-Rae Olsen1Cindy O’Hara2Lakshmi Puttagunta3Dilini Vethanayagam4Pulmonary Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaPulmonary Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaPulmonary Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaPulmonary Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaPulmonary Research Group, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaPeople with severe asthma account for 5% to 10% of all asthmatic patients; however, this small group uses the majority of health care resources. Novel methods are needed to cope with the burden that this minority of patients places on the health care system. A severe asthma clinic patient, who was monitored through the University of Alberta’s Virtual Asthma Clinic (Edmonton, Alberta) is presented. Despite optimization of his disease and individualized asthma education (provided by a certified asthma educator), the patient remained on oral glucocorticosteroids (OGS) to control his disease. Following optimization and stabilization, a further reduction in the dose of his OGS by the addition of the long-acting anticholinergic agent tiotropium bromide, was demonstrated. The role of tiotropium as a potential ‘steroid-sparing agent’ in severe refractory asthma is discussed, noting that if patients who are on OGS are not monitored for active inflammation, they may overuse the amount of prescribed systemic steroids, which can result in long-term steroid-related sequelae.http://dx.doi.org/10.1155/2009/206506 |
| spellingShingle | Anmol S Kapoor Sharla-Rae Olsen Cindy O’Hara Lakshmi Puttagunta Dilini Vethanayagam The Efficacy of Tiotropium as a Steroid-Sparing Agent in Severe Asthma Canadian Respiratory Journal |
| title | The Efficacy of Tiotropium as a Steroid-Sparing Agent in Severe Asthma |
| title_full | The Efficacy of Tiotropium as a Steroid-Sparing Agent in Severe Asthma |
| title_fullStr | The Efficacy of Tiotropium as a Steroid-Sparing Agent in Severe Asthma |
| title_full_unstemmed | The Efficacy of Tiotropium as a Steroid-Sparing Agent in Severe Asthma |
| title_short | The Efficacy of Tiotropium as a Steroid-Sparing Agent in Severe Asthma |
| title_sort | efficacy of tiotropium as a steroid sparing agent in severe asthma |
| url | http://dx.doi.org/10.1155/2009/206506 |
| work_keys_str_mv | AT anmolskapoor theefficacyoftiotropiumasasteroidsparingagentinsevereasthma AT sharlaraeolsen theefficacyoftiotropiumasasteroidsparingagentinsevereasthma AT cindyohara theefficacyoftiotropiumasasteroidsparingagentinsevereasthma AT lakshmiputtagunta theefficacyoftiotropiumasasteroidsparingagentinsevereasthma AT dilinivethanayagam theefficacyoftiotropiumasasteroidsparingagentinsevereasthma AT anmolskapoor efficacyoftiotropiumasasteroidsparingagentinsevereasthma AT sharlaraeolsen efficacyoftiotropiumasasteroidsparingagentinsevereasthma AT cindyohara efficacyoftiotropiumasasteroidsparingagentinsevereasthma AT lakshmiputtagunta efficacyoftiotropiumasasteroidsparingagentinsevereasthma AT dilinivethanayagam efficacyoftiotropiumasasteroidsparingagentinsevereasthma |